sb 204070a has been researched along with closantel in 1 studies
| Studies (sb 204070a) | Trials (sb 204070a) | Recent Studies (post-2010) (sb 204070a) | Studies (closantel) | Trials (closantel) | Recent Studies (post-2010) (closantel) |
|---|---|---|---|---|---|
| 45 | 0 | 4 | 208 | 18 | 81 |
| Protein | Taxonomy | sb 204070a (IC50) | closantel (IC50) |
|---|---|---|---|
| SUMO-1 | Homo sapiens (human) | 6.59 | |
| Solute carrier family 22 member 1 | Homo sapiens (human) | 3 | |
| Long-chain-fatty-acid--AMP ligase FadD32 | Mycobacterium tuberculosis H37Rv | 7.7 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.564 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 2.468 | |
| Tyrosine-protein kinase Lck | Homo sapiens (human) | 1.249 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.939 | |
| Sporulation initiation phosphotransferase F | Bacillus subtilis subsp. subtilis str. 168 | 3.8 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.096 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.65 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 2 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.096 | |
| Sporulation kinase A | Bacillus subtilis subsp. subtilis str. 168 | 3.8 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 1.8 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 7.1 | |
| Acetylcholinesterase | Homo sapiens (human) | 2.951 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.064 | |
| Mitogen-activated protein kinase 1 | Homo sapiens (human) | 1.428 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 1.839 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.096 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 2.65 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 4.8 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 0.656 | |
| Chitinase | Onchocerca volvulus | 1.6 | |
| 60 kDa chaperonin | Escherichia coli | 1.975 | |
| 10 kDa chaperonin | Escherichia coli | 1.975 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdeen, S; Chapman, E; Chitre, S; Hoang, QQ; Johnson, SM; Park, Y; Ray, AM; Salim, N; Sivinski, J; Stevens, M; Washburn, A | 1 |
1 other study(ies) available for sb 204070a and closantel
| Article | Year |
|---|---|
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive molecules.
Topics: Biological Products; Chaperonin 10; Chaperonin 60; Escherichia coli; Humans; Inhibitory Concentration 50; Protein Folding; Rafoxanide; Salicylanilides; Suramin | 2019 |